In 2019, Zhao et al. [107] observed that miR-451a exerted its anti-tumor effect by inactivating lipin 1 in the endothelial and neoplastic cells of hepatocellular carcinoma (HCC). The gene discussed is LPIN1; the disease is hepatocellular carcinoma.